Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 72603-746

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 72603-746). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (20 mg (90 Tablets Bottle))

Package Label-principal Display Panel (20 mg (90 Tablets Bottle))
Pantoprazole Sodium Delayed-Release Tablets, USP 40 mg oral tablets label by NorthStar Rx LLC. The label indicates a package containing 500 tablets, manufactured by Aurobindo Pharma Limited, India, with storage and dispensing instructions, barcode, and contact information for medication guides.*
FDA Label Image

Chemical Structure (Pantoprazole Str)

Chemical Structure (Pantoprazole Str)
Chemical structure of pantoprazole sodium, showing the arrangement of atoms including methoxy, difluoromethoxy, and sulfinyl functional groups, along with a sodium ion and associated water of hydration (1.5 H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.